Back

Bioresorbable vascular scaffolds for PCI – Represented in New England Journal of Medicin by the ABSORB III and AIDA trials.

27 August 2017 (16:52 - 17:15)
Organised by:
Congress Presentation Part of: Highlights from the New England Journal of Medicine: editors’ choice Miscellaneous ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Joanna J Wykrzykowska

University Medical Centre Groningen, Groningen (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
CSK9 inhibitors and cardiovascular outcomes – Represented in New England Journal of Medicine by the FOURIER and SPIRE trials.
Professor M. Sabatine (Boston, US)
Slides Video
Presentation thumbnail
ICD implantation for non-ischaemic cardiomyopathy – Represented in New England Journal of Medicine by the DANISH trial.
Professor L. Kober (Copenhagen, DK)
Slides Video
Presentation thumbnail
Prevention of recurrent venous thromboembolism – Represented in New England Journal of Medicine by several trials, including EINSTEIN, AMPLIFY, WARFASA, Hokusai-VTE, and others.
Doctor J. Weitz (Hamilton, CA)
Slides Video

Access the full session

Session thumbnail
Highlights from the New England Journal of Medicine: editors’ choice

The Event

Event poster

ESC Congress 2017

27 August 2017 16:52 CET
You may be interested in
thumbnail
Congress Presentation
Bioresorbable vascular scaffolds - a single center experience
9 March 2024
thumbnail
ESC TV Today
Episode 17: Coronary sinus reducer - Best strategies to reach LDL cholesterol goals
5 June 2025
thumbnail
Congress Presentation
Ct-guided PCI: a new continuum in coronary imaging and management
20 February 2026
thumbnail
Congress Presentation
A novel sirolimus-coated balloon versus a paclitaxel-coated balloon for coronary artery disease: the SELSEQ registry
20 February 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources